What is the current size of the active pharmaceutical ingredients market?

The global active pharmaceutical ingredients market size is expected to surpass around USD 384.51 billion by 2033 from accounted at USD 214.72 billion in 2023. Read More

Which prime factors stimulating the growth of the active pharmaceutical ingredients market globally?

Continuously growing prevalence of chronic illness, escalating significance of generics, and the cumulative uptake of biopharmaceuticals are some of the prime factors stimulating the growth of the active pharmaceutical ingredient market globally. Read More

Why active pharmaceutical ingredients?

Active Pharmaceutical Ingredients is the portion of drug that generates intentional effects. APIs are biologically and chemically active constituents of medicines with direct effect in mitigation, prevention, cure and treatment of diseases. Read More

How much is the CAGR of active pharmaceutical ingredients market?

The global active pharmaceutical ingredients market is expanding at a CAGR of 6.08% over the forecast period 2024 to 2033. Read More

Which segment is projected to be the fastest-growing segment in active pharmaceutical ingredients market?

Oncology is projected to be the fastest-growing segment driven by developing pervasiveness of cancer and cumulative lifestyle-associated sicknesses. Read More

Which are the applications in the active pharmaceutical ingredients market?

There are some applications in the active pharmaceutical ingredients market are orthopedic, pulmonology, gastroenterology, endocrinology, cardiology, oncology, CNS & neurology, nephrology, ophthalmology, Others Read More

Active Pharmaceutical Ingredients Market Size, Share, and Trends 2024 to 2033

Active Pharmaceutical Ingredients Market (By Synthesis: Biotech, Synthetic; By Type: Generic API, Innovative API; By Type of Manufacturer: Captive, Merchant; By Application: Cardiology, CNS & Neurology, Nephrology, Ophthalmology, Pulmonology, Gastroenterology, Oncology, Endocrinology, Others) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2024-2033

Last Updated : May 2024
Report Code : 1035
Category : Healthcare

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Active Pharmaceutical Ingredients Market

5.1. COVID-19 Landscape: Active Pharmaceutical Ingredients Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Active Pharmaceutical Ingredients Market, By Type of Synthesis

8.1. Active Pharmaceutical Ingredients Market Revenue and Volume Forecast, by Type of Synthesis, 2024-2033

8.1.1. Biotech

8.1.1.1. Market Revenue and Volume Forecast (2021-2033)

8.1.2. Synthetic

8.1.2.1. Market Revenue and Volume Forecast (2021-2033)

Chapter 9. Global Active Pharmaceutical Ingredients Market, By Type of Manufacturer

9.1. Active Pharmaceutical Ingredients Market Revenue and Volume Forecast, by Type of Manufacturer, 2024-2033

9.1.1. Captive APIs

9.1.1.1. Market Revenue and Volume Forecast (2021-2033)

9.1.2. Merchant APIs

9.1.2.1. Market Revenue and Volume Forecast (2021-2033)

Chapter 10. Global Active Pharmaceutical Ingredients Market, By Type

10.1. Active Pharmaceutical Ingredients Market Revenue and Volume Forecast, by Type, 2024-2033

10.1.1. Generic APIs

10.1.1.1. Market Revenue and Volume Forecast (2021-2033)

10.1.2. Innovative APIs

10.1.2.1. Market Revenue and Volume Forecast (2021-2033)

Chapter 11. Global Active Pharmaceutical Ingredients Market, By Application

11.1. Active Pharmaceutical Ingredients Market Revenue and Volume Forecast, by Application, 2024-2033

11.1.1. Cardiovascular Diseases

11.1.1.1. Market Revenue and Volume Forecast (2021-2033)

11.1.2. Oncology

11.1.2.1. Market Revenue and Volume Forecast (2021-2033)

11.1.3. CNS & Neurological Disorders

11.1.3.1. Market Revenue and Volume Forecast (2021-2033)

11.1.4. Orthopedic Disorders

11.1.4.1. Market Revenue and Volume Forecast (2021-2033)

11.1.5. Endocrinology

11.1.5.1. Market Revenue and Volume Forecast (2021-2033)

11.1.6. Pulmonology

11.1.6.1. Market Revenue and Volume Forecast (2021-2033)

11.1.7. Gastrointestinal Disorders

11.1.7.1. Market Revenue and Volume Forecast (2021-2033)

11.1.8. Nephrology

11.1.8.1. Market Revenue and Volume Forecast (2021-2033)

11.1.9. Ophthalmology

11.1.9.1. Market Revenue and Volume Forecast (2021-2033)

11.1.10. Others

11.1.10.1. Market Revenue and Volume Forecast (2021-2033)

Chapter 12. Global Active Pharmaceutical Ingredients Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Volume Forecast, by Type of Synthesis (2021-2033)

12.1.2. Market Revenue and Volume Forecast, by Type of Manufacturer (2021-2033)

12.1.3. Market Revenue and Volume Forecast, by Type (2021-2033)

12.1.4. Market Revenue and Volume Forecast, by Application (2021-2033)

12.1.5. U.S.

12.1.5.1. Market Revenue and Volume Forecast, by Type of Synthesis (2021-2033)

12.1.5.2. Market Revenue and Volume Forecast, by Type of Manufacturer (2021-2033)

12.1.5.3. Market Revenue and Volume Forecast, by Type (2021-2033)

12.1.5.4. Market Revenue and Volume Forecast, by Application (2021-2033)

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Volume Forecast, by Type of Synthesis (2021-2033)

12.1.6.2. Market Revenue and Volume Forecast, by Type of Manufacturer (2021-2033)

12.1.6.3. Market Revenue and Volume Forecast, by Type (2021-2033)

12.1.6.4. Market Revenue and Volume Forecast, by Application (2021-2033)

12.2. Europe

12.2.1. Market Revenue and Volume Forecast, by Type of Synthesis (2021-2033)

12.2.2. Market Revenue and Volume Forecast, by Type of Manufacturer (2021-2033)

12.2.3. Market Revenue and Volume Forecast, by Type (2021-2033)

12.2.4. Market Revenue and Volume Forecast, by Application (2021-2033)

12.2.5. UK

12.2.5.1. Market Revenue and Volume Forecast, by Type of Synthesis (2021-2033)

12.2.5.2. Market Revenue and Volume Forecast, by Type of Manufacturer (2021-2033)

12.2.5.3. Market Revenue and Volume Forecast, by Type (2021-2033)

12.2.5.4. Market Revenue and Volume Forecast, by Application (2021-2033)

12.2.6. Germany

12.2.6.1. Market Revenue and Volume Forecast, by Type of Synthesis (2021-2033)

12.2.6.2. Market Revenue and Volume Forecast, by Type of Manufacturer (2021-2033)

12.2.6.3. Market Revenue and Volume Forecast, by Type (2021-2033)

12.2.6.4. Market Revenue and Volume Forecast, by Application (2021-2033)

12.2.7. France

12.2.7.1. Market Revenue and Volume Forecast, by Type of Synthesis (2021-2033)

12.2.7.2. Market Revenue and Volume Forecast, by Type of Manufacturer (2021-2033)

12.2.7.3. Market Revenue and Volume Forecast, by Type (2021-2033)

12.2.7.4. Market Revenue and Volume Forecast, by Application (2021-2033)

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Volume Forecast, by Type of Synthesis (2021-2033)

12.2.8.2. Market Revenue and Volume Forecast, by Type of Manufacturer (2021-2033)

12.2.8.3. Market Revenue and Volume Forecast, by Type (2021-2033)

12.2.8.4. Market Revenue and Volume Forecast, by Application (2021-2033)

12.3. APAC

12.3.1. Market Revenue and Volume Forecast, by Type of Synthesis (2021-2033)

12.3.2. Market Revenue and Volume Forecast, by Type of Manufacturer (2021-2033)

12.3.3. Market Revenue and Volume Forecast, by Type (2021-2033)

12.3.4. Market Revenue and Volume Forecast, by Application (2021-2033)

12.3.5. India

12.3.5.1. Market Revenue and Volume Forecast, by Type of Synthesis (2021-2033)

12.3.5.2. Market Revenue and Volume Forecast, by Type of Manufacturer (2021-2033)

12.3.5.3. Market Revenue and Volume Forecast, by Type (2021-2033)

12.3.5.4. Market Revenue and Volume Forecast, by Application (2021-2033)

12.3.6. China

12.3.6.1. Market Revenue and Volume Forecast, by Type of Synthesis (2021-2033)

12.3.6.2. Market Revenue and Volume Forecast, by Type of Manufacturer (2021-2033)

12.3.6.3. Market Revenue and Volume Forecast, by Type (2021-2033)

12.3.6.4. Market Revenue and Volume Forecast, by Application (2021-2033)

12.3.7. Japan

12.3.7.1. Market Revenue and Volume Forecast, by Type of Synthesis (2021-2033)

12.3.7.2. Market Revenue and Volume Forecast, by Type of Manufacturer (2021-2033)

12.3.7.3. Market Revenue and Volume Forecast, by Type (2021-2033)

12.3.7.4. Market Revenue and Volume Forecast, by Application (2021-2033)

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Volume Forecast, by Type of Synthesis (2021-2033)

12.3.8.2. Market Revenue and Volume Forecast, by Type of Manufacturer (2021-2033)

12.3.8.3. Market Revenue and Volume Forecast, by Type (2021-2033)

12.3.8.4. Market Revenue and Volume Forecast, by Application (2021-2033)

12.4. MEA

12.4.1. Market Revenue and Volume Forecast, by Type of Synthesis (2021-2033)

12.4.2. Market Revenue and Volume Forecast, by Type of Manufacturer (2021-2033)

12.4.3. Market Revenue and Volume Forecast, by Type (2021-2033)

12.4.4. Market Revenue and Volume Forecast, by Application (2021-2033)

12.4.5. GCC

12.4.5.1. Market Revenue and Volume Forecast, by Type of Synthesis (2021-2033)

12.4.5.2. Market Revenue and Volume Forecast, by Type of Manufacturer (2021-2033)

12.4.5.3. Market Revenue and Volume Forecast, by Type (2021-2033)

12.4.5.4. Market Revenue and Volume Forecast, by Application (2021-2033)

12.4.6. North Africa

12.4.6.1. Market Revenue and Volume Forecast, by Type of Synthesis (2021-2033)

12.4.6.2. Market Revenue and Volume Forecast, by Type of Manufacturer (2021-2033)

12.4.6.3. Market Revenue and Volume Forecast, by Type (2021-2033)

12.4.6.4. Market Revenue and Volume Forecast, by Application (2021-2033)

12.4.7. South Africa

12.4.7.1. Market Revenue and Volume Forecast, by Type of Synthesis (2021-2033)

12.4.7.2. Market Revenue and Volume Forecast, by Type of Manufacturer (2021-2033)

12.4.7.3. Market Revenue and Volume Forecast, by Type (2021-2033)

12.4.7.4. Market Revenue and Volume Forecast, by Application (2021-2033)

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Volume Forecast, by Type of Synthesis (2021-2033)

12.4.8.2. Market Revenue and Volume Forecast, by Type of Manufacturer (2021-2033)

12.4.8.3. Market Revenue and Volume Forecast, by Type (2021-2033)

12.4.8.4. Market Revenue and Volume Forecast, by Application (2021-2033)

12.5. Latin America

12.5.1. Market Revenue and Volume Forecast, by Type of Synthesis (2021-2033)

12.5.2. Market Revenue and Volume Forecast, by Type of Manufacturer (2021-2033)

12.5.3. Market Revenue and Volume Forecast, by Type (2021-2033)

12.5.4. Market Revenue and Volume Forecast, by Application (2021-2033)

12.5.5. Brazil

12.5.5.1. Market Revenue and Volume Forecast, by Type of Synthesis (2021-2033)

12.5.5.2. Market Revenue and Volume Forecast, by Type of Manufacturer (2021-2033)

12.5.5.3. Market Revenue and Volume Forecast, by Type (2021-2033)

12.5.5.4. Market Revenue and Volume Forecast, by Application (2021-2033)

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Volume Forecast, by Type of Synthesis (2021-2033)

12.5.6.2. Market Revenue and Volume Forecast, by Type of Manufacturer (2021-2033)

12.5.6.3. Market Revenue and Volume Forecast, by Type (2021-2033)

12.5.6.4. Market Revenue and Volume Forecast, by Application (2021-2033)

Chapter 13. Company Profiles

13.1. Albemarle Corporation

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. AurobindoPharma

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. Reddy’s Laboratories Ltd.

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. AbbVieInc

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. Teva Pharmaceutical Industries Ltd

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. Mylan N.V.

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. CiplaInc

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. BoehringerIngelheim International GmbH

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. Merck & Co., Inc

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. Sun Pharmaceutical Industries Ltd

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms

We use cookies to improve your experience

Active Pharmaceutical Ingredients Market Size, Report 2024 To 2033

List of Contents